Cycloserine - Overview of species

 Cycloserine
 Cycloserine by the U.S. Eli Lilly and Company in the early 1970s developed the product, trade name: Seromycin. U.S. FDA approval in 1982, Eli Lilly and Company capsules market.
 Since 2000, Eli Lilly and Company through the World Health Organization in Asia, Africa and Europe, 40 countries received the approval of the listing. Zhejiang Sea are domestic drugs are drugs registered in July 2007 to declare the project; another Shanghai International Pharmaceutical Co., Ltd. in January 2003 to apply for registration, approval is now being imported during the period.

 Cycloserine - describe the nature of
 Colorless needle-like or leaf-shaped crystalline or amorphous powder. Melting point 155-156 ℃ (decomposition). Soluble in water, slightly soluble in methanol; ethanol; butanol; propylene glycol, isopropyl alcohol and acetone, insoluble or insoluble in toluene; chloroform; ether; pyridine; benzene and carbon disulfide.

 Cycloserine - the role of the function
 The role of anti-tuberculosis than isoniazid, streptomycin weak, but the hard-bacterial resistance, mainly for drug-resistant Mycobacterium tuberculosis infections

 Cycloserine - Dosage
 1st volume: Adult 0.5g; children 10mg/kg, 2 service, with half the amount of the first dose

 Cycloserine - Notes
 Toxic side effects, mainly the nervous system toxicity, gastrointestinal tract may have anti-fever.